Corporate Strategic M&A
A substantial portion of the transactions we handle are what many M&A participants would call “middle market” private transactions – even if the acquiror is a public company. These transactions vary substantially in size, industry, structure and complexity. These transactions all, however, share the fact that they are strategically important to the parties.
Corporate Strategic M&A transactions also often are handled partially by outside counsel and partially by the client’s existing staff (whether legal or other in-house experts). Our M&A lawyers understand how to partner effectively with our clients’ in-house staff to ensure we address the matters that need our attention, without duplicating efforts being undertaken in-house. We understand that the way a corporate buyer or seller approaches a potential transaction may differ significantly from the way a private equity sponsor approaches buying or selling a portfolio company in the typical private equity/leveraged buyout context.
Our Corporate Strategic M&A lawyers deliver comprehensive advice and practical results through a broad range of services for domestic and international clients. We regularly handle conventional and complex commercial transactions for public companies and privately held or family-owned enterprises. The services offered by our Corporate practice group are as diverse as our client base, enabling us to serve start-ups, entrepreneurs, middle-market companies, and some of the world’s most sophisticated industry leaders in mature and highly regulated industries.
A Haynes and Boone, LLP team led by Partners Rick Werner and Simin Sun represented LadRx Corporation in securing up to $11 million in non-dilutive financing from Xoma Corporation. LadRx, a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, announced June 22 that it has transferred the royalty and milestone rights associated with arimoclomol and aldo [...]